Miltenyi Biotec decides for TIS payment platform
Globally operating biotech company consolidates its banking landscape and creates more transparency and security in finance and international payments with TIS (Treasury Intelligence Solutions)
By: Treasury Intelligence Solutions GmbH
Miltenyi Biotec has grown steadily in recent years, especially in international markets. The company was founded in 1989 in Bergisch Gladbach, Germany, and specializes in products and processes for cellular research and cell therapy applications. Today, it has more than 3,000 employees worldwide, with 700 employees in research and clinical development. Miltenyi Biotec distributes its products through direct sales in 28 countries. The company's ongoing growth, increasing number of affiliates, banking partners and accounts led to a need to standardize the company's finance processes and to make them more efficient.
Besides accounts and payments consolidation, the company also wanted to make its payment processes more professional. In Germany, payment processes were structured with the Treasury Management System. Internationally, however, subsidiaries and affiliates used SAP and other ERP systems for payments and connected to banks via different online banking tools.
Daniel Pier, Group Leader Treasury at Miltenyi Biotec: "For our renewed banking landscape we looked for a centralized payments platform to make international payments more transparent and secure. With TIS, we can automate and standardize payments and monitor the processes from group treasury whenever necessary. For us, the core value of this solution is to enable us to follow closely the company-wide liquidity status at the push of a button."
Jörg Wiemer, co-founder and Chief Strategy Officer at TIS: "For fast growing companies, it is especially important to manage resources efficiently and meanwhile also ensure security and transparency in corporate payments and liquidity management. With its effective SAP integration and extensive bank connectivity, TIS offers powerful benefits to its customers. We are happy to welcome Miltenyi Biotec, a leading innovator in biomedical research and cellular therapy, to the TIS community."
Liang Fang, Marketing